Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (8)

2024

  1. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  2. In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression

    Cellular Oncology, Vol. 46, Núm. 3, pp. 697-715

2022

  1. Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy

    Nanoscale, Vol. 14, Núm. 22, pp. 8028-8040

2020

  1. Mutations in non-tumoral human urothelium: Disease prelude or epilogue?

    Bladder Cancer, Vol. 6, Núm. 3, pp. 249-252

2019

  1. Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872

  2. Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)

    Proceedings of the National Academy of Sciences of the United States of America

2018

  1. Enhanced cytotoxic activity of mitochondrial mechanical effectors in human lung carcinoma H520 cells: Pharmaceutical implications for cancer therapy

    Frontiers in Oncology, Vol. 8, Núm. NOV